AGXT Gene Mutations and Prevalence of Primary Hyperoxaluria Type 1 in Moroccan Population

被引:15
作者
Boualla, Lamiae [1 ,2 ]
Tajir, Mariam [2 ,3 ]
Oulahiane, Najat [4 ]
Lyahyai, Jaber [1 ,2 ]
Laarabi, Fatima Zahra [2 ]
Elalaoui, Siham Chafai [1 ,2 ]
Soulami, Kenza [5 ]
Ouamar, Hassan Ait [4 ]
Sefiani, Abdelaziz [1 ,2 ]
机构
[1] Univ Mohammed 5, Fac Med & Pharm, Ctr Genom Humaine, Rabat, Morocco
[2] Natl Inst Hyg, Dept Med Genet, Rabat, Morocco
[3] CHU Mohammed VI, Serv Genet, Marrakech, Morocco
[4] CHU Ibn Sina, Hop Enfant, Serv Pediat 4, Rabat, Morocco
[5] Cabinet Pediat Nephrol, Casablanca, Morocco
关键词
DIAGNOSIS; DISEASE; EXPERIENCE; CHILDREN; AFRICA; UPDATE;
D O I
10.1089/gtmb.2015.0136
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Introduction: Primary hyperoxaluria type 1 (PH1) is an autosomal recessive disorder caused by deficiency of alanine glyoxylate aminotransferase, due to a defect in the AGXT gene. Several mutations in this gene have been reported and some of them have been observed in multiple populations. The aim of our study was to analyze the mutations causing PH1 in the Moroccan population and to estimate its prevalence in Morocco. Methods: Molecular studies of 29 unrelated Moroccan patients with PH were performed by direct sequencing of all exons of the AGXT gene. In addition, to estimate the prevalence of PH1, we screened for the recurrent p.Ile244Thr mutation in 250 unrelated Moroccan newborns using real-time polymerase chain reaction. Results: Four pathogenic mutations were detected in 25 unrelated patients. The c.731T>C (p.Ile244Thr) was the most frequent mutation with a frequency of 84%. The other three mutations were c.33delC, c.976delG, and c.331C>T. The prevalence of the PH1 mutation among Moroccans was then estimated to range from 1/7267 to 1/6264. Conclusion: PH1 is one of the most prevalent genetic diseases in the Moroccan population and is probably underdiagnosed. Front line genetic testing for PH1 in Morocco should be initiated using an assay for the recurrent p.Ile244Thr mutation. This strategy would provide a useful tool for precocious diagnosis of presymptomatic individuals and to prevent their rapid progression to renal failure.
引用
收藏
页码:623 / 628
页数:6
相关论文
共 26 条
[1]   End-stage renal disease in Kuwaiti children: An 8-year experience [J].
Al-Eisa, AA ;
Samhan, M ;
Naseef, M .
TRANSPLANTATION PROCEEDINGS, 2004, 36 (06) :1788-1791
[2]  
Belhaj R, 2011, Pathol Biol (Paris), V59, pe97, DOI 10.1016/j.patbio.2009.05.009
[3]   EPIDEMIOLOGY OF PRIMARY HYPEROXALURIA TYPE-1 [J].
COCHAT, P ;
DELORAINE, A ;
ROTILY, M ;
OLIVE, F ;
LIPONSKI, I ;
DERIES, N .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 :3-7
[4]   Primary Hyperoxaluria [J].
Cochat, Pierre ;
Rumsby, Gill .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (07) :649-658
[5]   Primary hyperoxaluria [J].
Cochat, Pierre ;
Fargue, Sonia ;
Bacchetta, Justine ;
Bertholet-Thomas, Aurelia ;
Sabot, Jean-Francois ;
Harambat, Jerome .
NEPHROLOGIE & THERAPEUTIQUE, 2011, 7 (04) :249-259
[6]  
Coulter-Mackie M. B., 1993, GENEREVIEWS
[7]   Preliminary evidence for ethnic differences in primary hyperoxaluria type 1 genotype [J].
Coulter-Mackie, MB .
AMERICAN JOURNAL OF NEPHROLOGY, 2005, 25 (03) :264-268
[8]   Genetic heterogeneity in primary hyperoxaluria type 1: impact on diagnosis [J].
Coulter-Mackie, MB ;
Rumsby, G .
MOLECULAR GENETICS AND METABOLISM, 2004, 83 (1-2) :38-46
[9]   The AGT gene in Africa: a distinctive minor allele haplotype, a polymorphism (V326I), and a novel PH1 mutation (A112D) in black Africans [J].
Coulter-Mackie, MB ;
Tung, A ;
Henderson, HE ;
Toone, JR ;
Applegarth, DA .
MOLECULAR GENETICS AND METABOLISM, 2003, 78 (01) :44-50
[10]  
Danpure CJ, 2001, ONLINE METABOLIC MOL, P3323